Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease

NACompletedINTERVENTIONAL
Enrollment

1,569

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2011

Conditions
Lung CancerPrecancerous Condition
Interventions
OTHER

cytology and cytometry specimen collection procedure

Samples tested and further interventions added if positive

OTHER

Chest x ray

Patients not diagnosed with lung cancer during the course of the study, will be offered an exit chest x-ray after 5 years or sooner if they withdraw from the trial before 5 years. This could help identify a lung cancer that may not have been associated with symptoms earlier.

PROCEDURE

Autofluorescence bronchoscopy

The bronchial tree will be inspected first under white light and then under blue light. All areas that appear abnormal will initially be documented and only sampled when the bronchoscopic examination has been completed.

PROCEDURE

CT scan

All patients with abnormal sputum cytology and/or cytometry will undergo low dose spiral CT without contrast.

Trial Locations (10)

CB23 3RE

Papworth Hospital, Cambridge

CV2 2DX

Walsgrave Hospital, Coventry

LS1 3EX

Leeds General Infirmary, Leeds

LE3 9QP

University Hospitals of Leicester NHS Trust, Leicester

SW10 9NH

Chelsea Westminster Hospital, London

SW3 6NP

Royal Brompton Hospital, London

WC1E 5DB

University College Hospital - London, London

M23 9LT

Wythenshawe Hospital, Manchester

SR4 7TP

Sunderland Royal Hospital, Sunderland

BT9 7AB

Respiratory Research Office Belfast City Hospital, Belfast

All Listed Sponsors
lead

University College, London

OTHER

NCT00512746 - Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter